EcoDrugPlus

Tachykinin Receptor 3

Ensembl ID : ENSPKIG00000010824
Gene Symbol: TACR3
2 Cross references
198 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSPKIG00000017765
Gene Symbol: TACR3
1 Cross references
255 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSPKIG00000022342
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSPKIG00000016505
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPKIG00000001327
Gene Symbol: TBXA2R
1 Cross references
190 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPKIG00000001335
Gene Symbol: TBXA2R
3 Cross references
190 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSPKIG00000013893
Gene Symbol: TYMP
4 Cross references
174 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSPKIG00000010770
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSPKIG00000009906
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSPKIG00000012858
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSPKIG00000014640
Gene Symbol: LOC111839675
3 Cross references
194 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSPKIG00000008650
Gene Symbol: LOC111840144
3 Cross references
241 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).